SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21149243
Source:
http://linkedlifedata.com/resource/pubmed/id/21149243
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0017480
,
umls-concept:C0085550
,
umls-concept:C0162698
,
umls-concept:C0220812
,
umls-concept:C0542279
pubmed:issue
4
pubmed:dateCreated
2011-3-22
pubmed:abstractText
Comparison of overall RA-related costs and of relative contribution of single-cost domains before and after the introduction of TNF-blocking agents in Germany.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100883501
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1462-0332
pubmed:author
pubmed-author:BernateckMichaelM
,
pubmed-author:KirchhoffTimmT
,
pubmed-author:MauWilfriedW
,
pubmed-author:MerkesdalSonjaS
,
pubmed-author:MittendorfThomasT
,
pubmed-author:RihlMarkusM
,
pubmed-author:RuofJörgJ
,
pubmed-author:SchmidtReinhold ERE
,
pubmed-author:ZeidlerHenningH
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
756-61
pubmed:meshHeading
pubmed-meshheading:21149243-Adult
,
pubmed-meshheading:21149243-Aged
,
pubmed-meshheading:21149243-Antirheumatic Agents
,
pubmed-meshheading:21149243-Arthritis, Rheumatoid
,
pubmed-meshheading:21149243-Cohort Studies
,
pubmed-meshheading:21149243-Cost Savings
,
pubmed-meshheading:21149243-Cost of Illness
,
pubmed-meshheading:21149243-Cost-Benefit Analysis
,
pubmed-meshheading:21149243-Efficiency
,
pubmed-meshheading:21149243-Female
,
pubmed-meshheading:21149243-Germany
,
pubmed-meshheading:21149243-Health Care Costs
,
pubmed-meshheading:21149243-Hospitalization
,
pubmed-meshheading:21149243-Humans
,
pubmed-meshheading:21149243-Male
,
pubmed-meshheading:21149243-Middle Aged
,
pubmed-meshheading:21149243-Retrospective Studies
,
pubmed-meshheading:21149243-Treatment Outcome
,
pubmed-meshheading:21149243-Tumor Necrosis Factor-alpha
pubmed:year
2011
pubmed:articleTitle
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings.
pubmed:affiliation
Division of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't